Cargando…
Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244626/ https://www.ncbi.nlm.nih.gov/pubmed/28102301 http://dx.doi.org/10.1038/srep40272 |
| _version_ | 1782496727573463040 |
|---|---|
| author | Su, Shu Hu, Bian Shao, Jie Shen, Bin Du, Juan Du, Yinan Zhou, Jiankui Yu, Lixia Zhang, Lianru Chen, Fangjun Sha, Huizi Cheng, Lei Meng, Fanyan Zou, Zhengyun Huang, Xingxu Liu, Baorui |
| author_facet | Su, Shu Hu, Bian Shao, Jie Shen, Bin Du, Juan Du, Yinan Zhou, Jiankui Yu, Lixia Zhang, Lianru Chen, Fangjun Sha, Huizi Cheng, Lei Meng, Fanyan Zou, Zhengyun Huang, Xingxu Liu, Baorui |
| author_sort | Su, Shu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5244626 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52446262017-01-23 Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients Su, Shu Hu, Bian Shao, Jie Shen, Bin Du, Juan Du, Yinan Zhou, Jiankui Yu, Lixia Zhang, Lianru Chen, Fangjun Sha, Huizi Cheng, Lei Meng, Fanyan Zou, Zhengyun Huang, Xingxu Liu, Baorui Sci Rep Corrigenda Nature Publishing Group 2017-01-19 /pmc/articles/PMC5244626/ /pubmed/28102301 http://dx.doi.org/10.1038/srep40272 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Corrigenda Su, Shu Hu, Bian Shao, Jie Shen, Bin Du, Juan Du, Yinan Zhou, Jiankui Yu, Lixia Zhang, Lianru Chen, Fangjun Sha, Huizi Cheng, Lei Meng, Fanyan Zou, Zhengyun Huang, Xingxu Liu, Baorui Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title_full | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title_fullStr | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title_full_unstemmed | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title_short | Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients |
| title_sort | corrigendum: crispr-cas9 mediated efficient pd-1 disruption on human primary t cells from cancer patients |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244626/ https://www.ncbi.nlm.nih.gov/pubmed/28102301 http://dx.doi.org/10.1038/srep40272 |
| work_keys_str_mv | AT sushu corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT hubian corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT shaojie corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT shenbin corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT dujuan corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT duyinan corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT zhoujiankui corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT yulixia corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT zhanglianru corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT chenfangjun corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT shahuizi corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT chenglei corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT mengfanyan corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT zouzhengyun corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT huangxingxu corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients AT liubaorui corrigendumcrisprcas9mediatedefficientpd1disruptiononhumanprimarytcellsfromcancerpatients |